These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21613347)

  • 1. FDA is criticised for licensing high dose donepezil.
    Lenzer J
    BMJ; 2011 May; 342():d3270. PubMed ID: 21613347
    [No Abstract]   [Full Text] [Related]  

  • 2. How the FDA forgot the evidence: the case of donepezil 23 mg.
    Schwartz LM; Woloshin S
    BMJ; 2012 Mar; 344():e1086. PubMed ID: 22442352
    [No Abstract]   [Full Text] [Related]  

  • 3. Higher-dose (23 mg/day) donepezil formulation for the treatment of patients with moderate-to-severe Alzheimer's disease.
    Christensen DD
    Postgrad Med; 2012 Nov; 124(6):110-6. PubMed ID: 23322144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Another advertisement for donepezil.
    Finucane TE
    J Am Geriatr Soc; 2004 May; 52(5):843; author reply 845-6. PubMed ID: 15086674
    [No Abstract]   [Full Text] [Related]  

  • 5. Donepezil therapy for neuropsychiatric symptoms in AD: methods make the message.
    Herrmann N; Knopman D
    Neurology; 2004 Jul; 63(2):200-1. PubMed ID: 15277606
    [No Abstract]   [Full Text] [Related]  

  • 6. Brain injury, cognitive impairment, and donepezil.
    Whitlock JA
    J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
    [No Abstract]   [Full Text] [Related]  

  • 7. Ginkgo biloba extract EGb 761(R), donepezil or both combined in the treatment of Alzheimer's disease with neuropsychiatric features: a randomised, double-blind, exploratory trial.
    Yancheva S; Ihl R; Nikolova G; Panayotov P; Schlaefke S; Hoerr R;
    Aging Ment Health; 2009 Mar; 13(2):183-90. PubMed ID: 19347685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded use of Aricept.
    FDA Consum; 2007; 41(1):3. PubMed ID: 17354281
    [No Abstract]   [Full Text] [Related]  

  • 9. Donepezil delay to nursing home placement study is flawed.
    Karlawish JH
    J Am Geriatr Soc; 2004 May; 52(5):845; author reply 845-6. PubMed ID: 15086676
    [No Abstract]   [Full Text] [Related]  

  • 10. Switching from donepezil or rivastigmine to galantamine in clinical practice.
    Edwards K; Therriault O'connor J; Gorman C
    J Am Geriatr Soc; 2004 Nov; 52(11):1965. PubMed ID: 15507085
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical effects of high oral dose of donepezil for patients with Alzheimer's disease in Japan.
    Nozawa M; Ichimiya Y; Nozawa E; Utumi Y; Sugiyama H; Murayama N; Iseki E; Arai H
    Psychogeriatrics; 2009 Jun; 9(2):50-5. PubMed ID: 19604325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory.
    Baxter T; Black D; Prempeh H
    BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011
    [No Abstract]   [Full Text] [Related]  

  • 13. Mania associated with donepezil.
    Benazzi F
    J Psychiatry Neurosci; 1999 Nov; 24(5):468-9. PubMed ID: 10586539
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficacy, efficiency and evidence -- studies on donepezil].
    Wallesch CW; Ebert AD
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):555-6. PubMed ID: 15472778
    [No Abstract]   [Full Text] [Related]  

  • 15. First drug for moderate-to-severe Alzheimer's.
    FDA Consum; 2004; 38(1):3. PubMed ID: 15032183
    [No Abstract]   [Full Text] [Related]  

  • 16. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
    Liu HC; Lin SK; Sung SM
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early recognition not hopeless. Alzheimer disease can be delayed].
    MMW Fortschr Med; 2001 Feb; 143(6):60. PubMed ID: 11247376
    [No Abstract]   [Full Text] [Related]  

  • 18. Donepezil update.
    Drug Ther Bull; 1998 Aug; 36(8):60-1. PubMed ID: 9876403
    [No Abstract]   [Full Text] [Related]  

  • 19. Donepezil's effects remain uncertain.
    Royall DR
    J Am Geriatr Soc; 2004 May; 52(5):843-4; author reply 845-6. PubMed ID: 15086675
    [No Abstract]   [Full Text] [Related]  

  • 20. Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: results from a 24-week, double-blind, placebo-controlled, randomized trial.
    Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Ohbayashi T
    Dement Geriatr Cogn Disord; 2008; 25(5):399-407. PubMed ID: 18391486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.